학술논문
A Phase II Trial of TGFβ Type I Receptor Inhibitor, Galunisertib, plus Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer
Document Type
Abstract
Author
Yamazaki, T.; Gunderson, A.J.; Gilchrist, M.; Whiteford, M.; Kiely, M.X.; Hayman, A.; O'Brien, D.P.; Ahmad, R.; Manchio, J.V.; Fox, N.; McCarty, K.; Phillips, M.; Brosnan, E.; Vaccaro, G.; Li, R.; Simon, M.; Bernstein, E.; McCormick, M.; Yamasaki, L.; Drokin, A.; Carnahan, T.; To, Y.Y.; Redmond, W.L.; Lee, B.; Louie, J.; Hansen, E.K.; Solhjem, M.C.; Cramer, J.; Urba, W.J.; Gough, M.; Crittenden, M.R.; Young, K.H.
Source
In International Journal of Radiation Oncology, Biology, Physics 1 November 2022 114(3) Supplement:S104-S104
Subject
Language
ISSN
0360-3016